// App-Quantinova.ai

5529 : Cisplatin (C)-paclitaxel (P) chemotherapy (CT) regimen with concurrent radiotherapy (RT) in local advanced (LACC) or recurrent (LRCC) cervical cancer: 14 year-results of a phase II study.

Researchers

Presenter

  • Milena Bruzzone

Principal Investigators

  • Chiara Dellepiane

  • Elisa Bo

  • Alessia Cavo

  • Flavio Giannelli

  • Maria Grazia Centurioni

  • Maurizio Cosso

  • Franco Alessandri

  • Valerio Gaetano Vellone

  • Rodolfo Sirito

  • Elisa Zanardi

  • Giulia Buzzatti

  • Carlo Messina

  • Carlo Cattrini

  • Claudio Gustavino

  • Francesco Boccardo

Medical Centers

  • Academic Unit of Medical Oncology, IRCCS San Martino University Hospital - IST National Cancer Research Institute, Genoa, Italy

  • University of Genoa, Department of Internal Medicine, School of Medicine, Genoa, Italy

  • Academic Unit of Medical Oncology, IRCCS San Martino University Hospital - IST National Cancer Research Institute, Genoa, Italy

  • Academic Unit of Medical Oncology, IRCCS San Martino University Hospital - IST National Cancer Research Institute, Genoa, Italy

  • Academic Unit of Medical Oncology, IRCCS San Martino University Hospital - IST National Cancer Research Institute, Genoa, Italy

  • University of Genoa, Anatomic Pathology Unit, Department of Surgical Sciences and Integrated Diagnostics (DISC), Genova, Italy

  • Obstetric Gynecology OEI, Genoa, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Cervical cancer

  • Multiple cutaneous and uterine leiomyomata

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Paclitaxel

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved